W. Messersmith
Impact in
-
- Drug Transport and Resistance Mechanisms
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 7
- Colorectal Cancer Treatments and Studies 3
- Cancer Treatment and Pharmacology 3
- Cancer-related Molecular Pathways 1
-
- Melanoma and MAPK Pathways 1
- Co-authors
- Alasdair Scott (1 shared paper)Antonio Jimeno (1 shared paper)Sharyn D. Baker (3 shared papers)Vishal Lamba (1 shared paper)Alex Sparreboom (1 shared paper)Antonio C. Wolff (1 shared paper)Jaap Verweij (1 shared paper)Sharon Marsh (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)Drugs of today (1 paper)Clinical Pharmacology & Therapeutics (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- United StatesNetherlands
In The Last Decade
W. Messersmith
9 papers receiving 296 citations
Peers
Comparison fields: 5 of 51
- Oncology 206
- Pharmacology 55
- Hepatology 23
- Cancer Research 41
- Pulmonary and Respiratory Medicine 87
Countries citing papers authored by W. Messersmith
This map shows the geographic impact of W. Messersmith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Messersmith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Messersmith more than expected).
Fields of papers citing papers by W. Messersmith
This network shows the impact of papers produced by W. Messersmith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Messersmith. The network helps show where W. Messersmith may publish in the future.
Co-authors
The 25 scholars most cited alongside W. Messersmith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 139 | |
| 2 | 2015 | 125 | |
| 3 | 2009 | 13 | |
| 4 | 2006 | 11 | |
| 5 | 2009 | 7 | |
| 6 | 2012 | 3 | |
| 7 | 2006 | 2 | |
| 8 | 2008 | 1 | |
| 9 | 2010 | 1 |
About W. Messersmith
W. Messersmith is a scholar working on Oncology, Molecular Biology, Cancer Research, Pharmacology and Pathology and Forensic Medicine, having authored 9 papers that have together received 302 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (3 papers), Cancer Treatment and Pharmacology (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Pharmacological Effects and Toxicity Studies (1 paper), Cancer Genomics and Diagnostics (1 paper), Cancer-related Molecular Pathways (1 paper) and Melanoma and MAPK Pathways (1 paper). The work is most often cited by research in Oncology (206 citations), Pharmacology (55 citations), Hepatology (23 citations), Cancer Research (41 citations) and Pulmonary and Respiratory Medicine (87 citations). W. Messersmith has collaborated with scholars based in United States and Netherlands. Frequent co-authors include Alasdair Scott, Antonio Jimeno, Sharyn D. Baker, Vishal Lamba, Alex Sparreboom, Antonio C. Wolff, Jaap Verweij, Sharon Marsh, Shuiying Hu and Katherine Galvin. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Drugs of today, Clinical Pharmacology & Therapeutics and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.